LTS Nutraceuticals acquires Biocalth International, Giantceuticals, and HerbSource Enterprises

LTS Nutraceuticals, Inc. (the “Company”) (OTCBB: LTSN), a developer and manufacturer of nutritional and personal care products, today announced that the Company has completed its acquisition of Biocalth International, Inc., Giantceuticals, Inc. and HerbSource Enterprises, Inc. (collectively “Biocalth”). The combined businesses manufacture nutraceutical products in the U.S. and market and sell in Asia and Europe.

Established in 2001, Biocalth International Inc. is a leader in the development of proprietary nutritionals with special emphasis on calcium supplementation. HerbSource Enterprises, Inc., a division of Biocalth is a worldwide supplier of high quality natural botanical extracts, vitamin formulations, food additives and state-of-the-art chemistry. Raw materials supplied by Biocalth meet all regulatory standards for purity and efficacy. Biocalth also maintains approximately 25,000 sq. ft. of good manufacturing practice (“GMP”), state-of-the-art facility and the facility meets all government standards required by the United States and European governments and pharmaceutical agencies.

Biocalth produces a complete line of award winning products that promote bone health. Biocalth® is a unique, patented Calcium L-Threonate supplement that is scientifically proven to improve bone density and encourage the formulation of cartilage and collagen to strengthen bones.* The Company will begin marketing and distributing Biocalth products throughout the U.S., expanding its revenue opportunities in the largest bone health and joint health market in the world. According to an article in News-Medical.Net (September 2011), the bone and joint health supplements market is forecasted to be worth over $9 billion by 2017 worldwide.

“The acquisition of Biocalth was a strategic opportunity for us to capitalize on a manufacturing facility as well as to penetrate the Asian markets with our existing products. We are also excited to begin marketing Biocalth for the first time here in the U.S. through our retail channels. We believe there will be a strong product demand in the U.S. as ‘baby boomers’ continue to search for the best supplements that could help them take preventive measures in combating various bone conditions,” stated CEO of LTS Nutraceuticals, Jerry Rayman.

President and CEO of Biocalth, Jackson Wen stated, “I believe combining our businesses will allow for rapid revenue growth as we strive to become a global powerhouse within the nutraceutical market. Biocalth is a leader in the Asian markets and we look forward to seeing the same success in the U.S.”